Research programme: retinal degeneration therapy - Lexicon Genetics
Alternative Names: LG339 inhibitors research programme - Lexicon Genetics; Retinal degeneration therapy research programme - Lexicon GeneticsLatest Information Update: 31 May 2006
Price :
$50 *
At a glance
- Originator Lexicon Genetics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Retinal disorders
Most Recent Events
- 31 May 2006 No development reported - Preclinical for Retinal disorders in USA (unspecified route)
- 18 Jan 2005 Preclinical trials in Retinal disorders in USA (unspecified route)